Why the study?
Few studies have examined the prognostic value of the triglyceride glucose (TyG) index for cardiovascular disease in patients diagnosed with CKD, particularly those with advanced CKD.
Does the Triglyceride glucose (TyG) index predict cardiovascular death and heart failure-related rehospitalization in patients with non-dialysis CKD stage 3-5?
Does the Triglyceride glucose (TyG) index predict cardiovascular death and heart failure-related rehospitalization in patients with non-dialysis CKD stage 3-5?
The Triglyceride glucose (TyG) index is a significant independent prognostic marker for heart failure and cardiovascular death in patients with advanced non-dialysis chronic kidney disease.
May aid HF risk stratification in advanced non-dialysis CKD; leaves open prospective trials before any practice change.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: